InnoGI Technologies (formerly The TIM Company) provides innovative CRO services to the Pharmaceutical Industry related to Gastrointestinal (GI) research and Oral Drug Delivery. It utilizes the most advanced and accurate gastrointestinal technology, mimicking the dynamics of a real human gut (SurroGUT™).

Our SurroGUT™ platform offers the TIM systems, a technology that is able to mimic the human GI tract with a correlation range of 76% to 99.9% with human formulation rankings. This innovative solution provides enhanced predictive capabilities, aiming to improve the overall probability of success, also in preparation for clinical trials.

InnoGI Technologies, headquartered in Delft, The Netherlands, offers a range of research services addressing complex formulation issues in oral drug candidates which can lead to decreased formulation iterations, effectively de-risked clinical trials, and shortened time-to-market. InnoGI Technologies is driven by the goal of developing innovative technologies and solutions related to realistic GI tract simulations and oral drug delivery for Pharma and Food.